Advanced search

Instruments

Name		Stock exchange	Average volume	Price	Type
ALBERT DAVID LIMITED	ALBERTDAVD	Bombay S.E. +1 Other	1,641	1,173 INR	Stock
ALBERT DAVID LIMITED	ALBERTDAVD	NSE India S.E.	10,374	1,171 INR
EEDUCATION ALBERT AB	ALBERT	Nasdaq Stockholm +1 Other	14,903	4 SEK	Stock
EEDUCATION ALBERT AB	9IX	Deutsche Boerse AG	-	1.12 EUR
ALBERT LABS INTERNATIONAL CORP.	ABRT	Canadian Securities Exchange +2 Other	123,720	0.015 CAD	Stock
ALBERT LABS INTERNATIONAL CORP.	VB50	Deutsche Boerse AG	-	0.003 EUR
ALBERT LABS INTERNATIONAL CORP.	ALBLF	OTC Markets	-	- USD
ALBERT LABS INTERNATIONAL CORP.	ABRT	Canadian Securities Exchange	57,960	0.015 CAD	Stock

News (981)

Pfizer Names Andrew Baum Chief Strategy, Innovation Officer	05-06	DJ
Pfizer Announces New Chief Strategy and Innovation Officer	05-06	BU
Pfizer Announces Executive Changes	05-06	CI
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Prepared Remarks	05-02	PU
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Infographic	05-02	PU
Pfizer : Quarterly Corporate Performance - First Quarter 2024 Press Release	05-02	PU
Pfizer : April Social Media Round-Up—Black Maternal Health, World Immunization, and Long Covid	05-02	PU
Trending : Pfizer 1Q Earnings Top Estimates; Raises FY24 View	05-01	DJ
Transcript : Pfizer Inc., Q1 2024 Earnings Call, May 01, 2024	05-01
Pfizer Earnings Top Views; Boosts Full-Year Guidance	05-01	DJ
Pfizer Reports First-Quarter 2024 Results	05-01	BU
Pfizer : March Social Media Round-Up—Annual Review, International Women’s Day, and a School of Science Celebration	04-09	PU
China to speed up 'new productive forces', vice president says	03-26	RE
German industry sceptical of China's vow to treat foreign firms equally	03-25	RE
Pfizer : Oncology Innovation Day Transcript	03-03	PU
Transcript : Pfizer Inc. - Special Call	02-29
Pfizer : Oncology Innovation Day Presentation	02-28	PU
Transcript : Pfizer Inc., Q4 2023 Earnings Call, Jan 30, 2024	01-30
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance	01-30	BU
Weight loss drug windfall attracts pharma companies	01-11	RE
Drugmakers plot way into obesity market with deals and development	01-11	RE
Global markets live: Boeing, GSK, Hays, Shell, Eli Lilly...	01-09
Nvidia comes to Wall Street's rescue	01-09
Transcript : Pfizer Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:00 PM	01-08
Pfizer to remain aggressive on obesity market after setback	01-08	RE
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference	01-02	BU
North American Morning Briefing: Volatility Likely as Traders Brace for Options Expiration	12-15	DJ
Pfizer Declares First-Quarter 2024 Dividend	12-14	BU
Pfizer Completes Acquisition of Seagen	12-14	BU
Pfizer shares sink after it resets 2024 COVID expectations	12-13	RE
Switch from selling COVID-19 drugs on market rather than to governments continues to sting at Pfizer	12-13	AQ
Transcript : Pfizer Inc., Seagen Inc. - M&A Call	12-13
Pfizer Provides Full-Year 2024 Guidance	12-13	BU
Pfizer Inc. Announces Management Changes	12-12	CI
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen	12-12	BU
Xi tells US firms China ready to be partner and friend	11-16	RE
Transcript : Pfizer Inc. Presents at Truist Securities 2023 BioPharma Symposium, Nov-09-2023 12:35 PM	11-09
Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs	23-10-31	MT
Pfizer CEO Albert Bourla: Seagen will bring in $10 billion in revenues by 2030	23-10-31	MT
Transcript : Pfizer Inc., Q3 2023 Earnings Call, Oct 31, 2023	23-10-31
Pfizer Reports Third-Quarter 2023 Results	23-10-31	BU
Antitrust & Competition Life Sciences Quarterly Update Q3 2023	23-10-25	AQ
Transcript : Pfizer Inc. - Shareholder/Analyst Call	23-10-16
Pfizer Slashes Fiscal Year Guidance as It Lowers Revenue From Covid-19 Treatments by $9 Billion	23-10-13	DJ
US banks, tech firms offer support for Israel victims, announce aid	23-10-13	RE

1234NextSee all

Companies (17)

AHOLD DELHAIZE N.V. 29 667 M $

Ahold Delhaize N.V. is one of the world leaders in retailing. Net sales break down by activity as follows: - retail distribution in the United States (61.5%): operated, at the end of 2023, 2,048 stores broken down by names between Food Lion (1,108), Stop ...

KONINKLIJKE AHOLD DELHAIZE N.V. 29 667 M $

FORTUNE BRANDS INNOVATIONS, INC. 9 406 M $

Fortune Brands Innovations, Inc. is a home, security and commercial building products company. The Company has three segments. Water Innovations segment manufactures or assembles and sells faucets, accessories, kitchen sinks and waste disposal, predominan ...

EEDUCATION ALBERT AB 9 M $

eEducation Albert AB is a Sweden-based provider of educational support services. The Company offers software children's digital teacher, which aims to help families with homework via mobile devices. Albert's apps are aimed at younger (3-9 years) and older ...

FATHOM NICKEL INC. 7 M $

Fathom Nickel Inc. is a Canada-based exploration company. The Company targets magmatic nickel sulphide discoveries to support the rapidly growing global electric vehicle market. The Company has a portfolio of two exploration projects located in the prolif ...

SAYONA MINING LIMITED 323 M $

Sayona Mining Limited is an Australia-based lithium producer with projects in Quebec, Canada and Western Australia. The Company's projects include Authier Lithium Project, Tansim Lithium Project, Moblan Lithium Project, Lac Albert Lithium Project, Western ...

VOYAGEUR MINERAL EXPLORERS CORP. 10 M $

Voyageur Mineral Explorers Corp. is a Canadian junior mineral exploration company with a specific focus on mineral properties in Northwest Manitoba and Northeast Saskatchewan, Canada. The Company owns a package of royalty assets in the Flin Flon camp, and ...

ALBERT LABS INTERNATIONAL CORP. 820 529 $

Albert Labs International Corp. is a Canada-based pharmaceutical drug development company. The Company is focused on active compounds in the treatment of mental health and providing rapid access to effective prescription medicines for people suffering fro ...

EAGLE ROYALTIES LTD. 5 M $

Eagle Royalties Ltd. is engaged in holding royalty assets. The Company holds royalty interests on approximately 40 mineral exploration projects in western Canada. These projects are being explored for commodities that include gold, silver, critical metals ...

ALBERT DAVID LIMITED 80 M $

Albert David Limited is engaged in manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. The Company offers its products under various categories, which includes ...

12Next

Insiders

Albert Bourla

Albert Bourla is Chairman, Chief Executive & Operating Officer at Pfizer Inc., Member of The Business Roundtable and Member of The Business Council and on the board of 7 other companies. Dr. Bourla received a doctorate from School of Veterinary Medicine (Greece).

Albert Curtis Sebastian

Mr. Albert C.
Sebastian, CFA MBA, is President & Chief Compliance Officer at Prospect Advisors LLC.
He founded the firm in 2010.
Mr. Sebastian was previously employed as an Investment Manager by Ironbound Capital Management LP and Vice President by USAA Investment Management Co. He received his undergraduate degree from Holy Cross College (Indiana) and an MBA from the University of Michigan.

Albert Leung

Albert Leung is currently working as an Emerging Markets Asia Rates Strategist at Nomura International (Hong Kong) Ltd.
since 2015.
Prior to this, he worked as an Emerging Asia Fixed Income Strategist at Merrill Lynch Far East Ltd.

Albert Dauray

Albert Dauray worked as a Vice President of Information Technology at AVEO Pharmaceuticals, Inc..
Mr. Dauray attended Bentley University for graduate studies and Franklin Pierce College for undergraduate studies.

Albert Letayf

Albert Cuisinot

No results for this search